John Wongvipat

Pulmonary and Respiratory Medicine · 2003–2017

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom John Wongvipat trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Sawyers (in Pulmonary and Respiratory Medicine)

Papers from John Wongvipat's perspective

Ordered by how strongly the researchers John Wongvipat trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. (Cancer Cell)
  2. Molecular determinants of resistance to antiandrogen therapy (Nature Medicine)
  3. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. (Molecules and Cells)
  4. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. (Cancer Cell)
  5. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. (Molecules and Cells)
  6. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (Nature Genetics)
  7. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
  8. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
  9. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. (Journal of Clinical Investigation)
  10. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. (Cancer Research)

Their papers